- Rohinton T Kamakaka:
- Provided us with S. cerevisiae yeast starter cultures and plasmid backbones for
transfection of our DNA construct into E. coli
- Advised us on utilization of the MoClo library, and proper
safety and handling of yeast in lab
- Supported our wet lab in the homologous repair of S. cerevisiae to contain Ex-4
- Rebecca DuBois:
- Provided us with TEV protease expressing
E. coli, Histidine Antibodies, and other lab materials
- Had extensive correspondence and advised us in preparation and troubleshooting for
protein expression, purification, and SDS-PAGE results
- Helped us prepare assays for bio-layer interferometry using her lab's Octet machine
for Ex-4's binding affinity analysis
- Samuel Pine:
- Mentored our team from Belgium and advised us on the overall direction of our project
including next steps in the wet lab and Ex-4 bioavailability via bi-weekly virtual
meetings
- Provided valuable feedback on Helo's implementation and connecting our vision to a
marketable product
- Guided us to discussions with experts at Sanofi specifically in relation to half life
extenders and fundraising
- Suz Howells:
- Facilitated interactions with UC Santa Cruz alumni at Midtown Takeover event and engaged
in collaboration efforts to shared our project to the community
- Guided us through The Spring Give, a fundraising event that allowed us to raise money to
carry out our project
- Provided us with ample contacts to speak to professionals such as endocrinologists and
global health specialists
- Provided us a connection with Melissa Weckerle, Communications Specialist at UC Santa
Cruz, who interviewed members of our team and wrote an article about the work we have
been doing. This allowed for a platform in which the community could see our project and
reach out to our team
- Helped us get a room in which we could host Soquel High School students and helped organize logistics for permission slips
We would additionally like to acknowledge the following individuals for their contributions to
Helo:
Dr. Patricia Wu (Kaiser Permanente) for their explanation of medical consensus on current
diabetes treatment, Dr. John Demko (University of California, San Francisco) and Dr.
Sunder
Mudaliar (University of California, San Diego) for giving us background on GLP-1 RA
therapeutics, Dr. Matt Sparke (University of California, Santa Cruz) for building our
background
about global health and communities lacking diabetes care, Dr. Somen Nandi (University of
California, Davis) for advice on Agrobacterium-mediated gene transfer and transgenic plants, Dr.
Lawrence DeGhetaldi (Palo Alto Medical Foundation) for insight on the feasibility of Helo
being
adopted into patient care, Jessica Bulleri (Diabetes Prevention Program, Santa Cruz) for
sharing
general background on pre-diabetes, Ted Malpass (University of California, Santa Cruz) for
connecting us with Universities Allied for Essential Medicine to enhance the scope of our
outreach, Dr. David Ghilarducci (Deputy Health Officer and EMS Medical Director, Santa Cruz)
for
presenting to us about the pathology of diabetes and common treatment mechanisms, Dr. Sebastian
Bernales (Co-Founder and Board Member at Metagenomi) for advising and proposing questions
about
the implementation of Helo, Alexander Wolf (Dean of Baskin Engineering) and Paul L
Koch (Dean of
Physical & Biological Sciences Division) for helping fund Helo.